{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:27:08Z","timestamp":1776396428647,"version":"3.51.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vaccine.2024.04.032","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T08:10:34Z","timestamp":1712823034000},"page":"3333-3336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents"],"prefix":"10.1016","volume":"42","author":[{"given":"Jue Seong","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HyoSug","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Jae","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangshin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonsun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-4275","authenticated-orcid":false,"given":"Bin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-5203","authenticated-orcid":false,"given":"Kyoungsan","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young June","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.032_b0005","doi-asserted-by":"crossref","first-page":"e065687","DOI":"10.1136\/bmjopen-2022-065687","article-title":"Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis","volume":"13","author":"Alami","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.04.032_b0010","first-page":"e069445","article-title":"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review","volume":"378","author":"Pillay","year":"2022","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.vaccine.2024.04.032_b0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of Myocarditis among vaccine recipients: update from the Advisory committee on immunization Practices - United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.04.032_b0020","first-page":"7","article-title":"Considerations for vaccinating children against COVID-19","author":"Hart","year":"2023","journal-title":"BMJ paediatrics open"},{"key":"10.1016\/j.vaccine.2024.04.032_b0025","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.032_b0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(03)00511-5","article-title":"Standardized case definitions of adverse events following immunization (AEFI)","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.032_b0035","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.vaccine.2021.11.074","article-title":"Myocarditis and pericarditis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"40","author":"Sexson Tejtel","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.032_b0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clicom.2022.11.001","article-title":"Myocarditis following coronavirus vaccination","volume":"2","author":"Ferchichi","year":"2022","journal-title":"Clin Immunol Commun"},{"key":"10.1016\/j.vaccine.2024.04.032_b0045","first-page":"128","article-title":"Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines","author":"Gedeborg","year":"2023","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.vaccine.2024.04.032_b0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.24171\/j.phrp.2022.0122","article-title":"Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea","volume":"13","author":"Kim","year":"2022","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.vaccine.2024.04.032_b0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7774\/cevr.2013.2.1.40","article-title":"Management of vaccine safety in Korea","volume":"2","author":"Choe","year":"2013","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2024.04.032_b0060","first-page":"6","article-title":"Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12\u201317-year olds in Victoria, Australia","author":"Cheng","year":"2022","journal-title":"BMJ Paediatrics Open"},{"key":"10.1016\/j.vaccine.2024.04.032_b0065","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.032_b0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral Myocarditis-incidence, diagnosis and Management","volume":"34","author":"Olejniczak","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.vaccine.2024.04.032_b0075","first-page":"6","article-title":"Occurrence and features of childhood Myocarditis: a nationwide study in Finland","author":"Arola","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.vaccine.2024.04.032_b0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/s12889-023-15539-5","article-title":"Global, regional, and national burdens of myocarditis, 1990\u20132019: systematic analysis from GBD 2019: GBD for myocarditis","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2024.04.032_b0085","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.3346\/jkms.2021.36.e232","article-title":"Epidemiology and clinical features of myocarditis\/pericarditis before the introduction of mRNA COVID-19 vaccine in Korean children: a multicenter study","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T15:30:12Z","timestamp":1729611012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24004468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0264410X24004468"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}